The effect of cerebral ischemia on the activity of pyruvate dehydrogenase (PDH) enzyme complex (PDHC) was investigated in homogenates of frozen rat cerebral cortex following 15 min of bilateral common ca rotid occlusion ischemia and following 15 min, 60 min, and 6 h of recirculation after 15 min of ischemia. In frozen cortical tissue from the same animals, the levels of labile phosphate compounds, glucose, glycogen, lactate, and pyruvate were determined. In cortex from control ani mals, the rate of [l_14C]pyruvate decarboxylation was 9.6 ± 0.5 nmol CO2/(min-mg protein) or 40% of the total PDHC activity. This fraction increased to 89% at the end of 15 min of ischemia. At 15 min of recirculation following 15 min of ischemia, the PDHC activity decreased to 50% of control levels and was depressed for up to 6 h post ischemia. This decrease in activity was not due to a de crease in total PDHC activity. Apart from a reduction in ATP levels, the acute changes in the levels of energy metabolites were essentially normalized at 6 h of recov ery. Dichloroacetate (DCA), an inhibitor of PDH kinase, given to rats at 250 mg/kg i.p. four times over 2 h, signif-
The pyruvate dehydrogenase (POH) complex (POHC) is a mitochondrial multienzyme complex composed of three enzyme activities, participating in the decarboxylation of pyruvate and formation of acetyl-CoA (Reed, 1981) . It is a central enzyme in the metabolism of glucose and in acetylcholine syn thesis (Tucek and Cheng, 1974; Gibson et aI. , 1975) , but has also been proposed to be important in neu ronal plasticity and accommodative processes via effects on the cellular calcium ion homeostasis (Morgan and Routtenberg, 1981; Browning et aI. , 1981; Baudry and Lynch, 1985) .
icantly decreased blood glucose levels from 7.4 ± 0.6 to 5.1 ± 0.3 mmoUL and fully activated PDHC. In animals in which the plasma glucose level was maintained at control levels of 8. 3 ± 0.5 IJ-mol/g by intravenous infusion of glu cose, the active portion of PDHC increased to 95 ± 4%. In contrast, the depressed PDHC activity at 15 min fol lowing ischemia was not affected by the DCA treatment. In both DCA + glucose-treated control and recovery groups, the pyruvate levels decreased by 50%. No signif icant difference in the lactate levels was seen. We con clude that the depressed postischemic PDHC activity is not due to loss of enzyme protein nor to an increased PDH kinase activity, but is probably due to a decreased activity of PDH phosphatase. This could in turn be sec ondary to a change in the cellular levels of PDH phos phatase regulators, most probably a decreased intramito chondrial concentration of calcium. The postischemic de crease in PDH activity may be related to the postischemic metabolic depression. Key Words: Brain-Dichloro acetate-Ischemia-Pyruvate dehydrogenase-Rat.
Phosphorylation-dephosphorylation of the a-subunit protein of POHC regulates the enzyme activity via reactions catalyzed by a PDH phos phatase that activates, and a PDH kinase that inac tivates, the enzyme (for review see Reed, 1981; Randle, 1981) . These enzymes in turn are modu lated by metabolites of intermediary metabolism and divalent ions (Wieland, 1983; Hansford, 1985) . Brain PDH kinase and phosphatase have similar properties to those found in peripheral tissue (Booth and Clark, 1978; Sheu et aI., 1983 Sheu et aI., , 1984 , but the regulation of brain PDHC is still not fully un derstood (Kauppinen and Nicholls, 1986; Lai and Sheu, 1985) . Apart from regulation of PDHC by feedback inhibition by metabolites of intermediary metabolism, external influences such as neurotrans mitters and neuromodulators may change the activ ity of the enzyme via second messenger systems (Hershkowitz, 1978; Sieghart, 1981; Hofstein and Segal, 1982) . Recently a concept of hormonal action via cellular "stimulus-response-metabolism" cou pling was presented (McCormack and Denton, 1986) .
During recent years the involvement of PDHC in neurological disease, in particular the neurodegen erative disorders (Blass and Gibson, 1978) such as Huntington's and Alzheimer's disease (Sorbi et aI., 1983; Sheu et aI., 1985) , has been recognized. Al though the PDHC activity has been investigated thoroughly in the ischemic brain, the postischemic changes in the enzyme activity have not been de scribed. The aim of the present investigation was to elucidate the influence of transient cerebral isch emia on the postischemic cortical PDHC activity in relation to the cerebral energy state and lactate and pyruvate levels and to study whether a possible change in PDHC activity could be affected by dichloroacetate (DCA), a PDHC kinase inhibitor (Whitehouse and Randle, 1973; Whitehouse et aI. , 1974) . A preliminary account of these results has been presented (Wieloch and Koide, 1987) .
MATERIALS AND METHODS

Animals and operative techniques
All experiments were performed on male Wistar rats (350-400 g) of an S.P.F. strain (Mj<jllegaard Avlslaborato rium, Copenhagen), fasted overnight prior to the experi ments. The animals were initially immersed in an atmo sphere of 3% halothane, tracheotomized, and artificially ventilated with a mixture of 0.6% halothane in 30% O2 and 70% N20 during the subsequent operation. The fem oral arteries and one femoral vein were cannulated for blood sampling, continuous blood pressure recording, and intravenous injections. The skin was incised over the skull bone to accommodate a plastic funnel for later freez ing of the tissue in situ. The animals were paralyzed with tubocurarine chloride (0.5 mg i. v.) and given heparin (100 IV i.v.). After completion of the surgical procedures, the halothane supply was discontinued and ventilation was adjusted to give arterial oxygen (P a02) and carbon dioxide (Pac02) tensions of �100 and 35-40 mm Hg, respectively. The EEG was intermittently recorded from gold-plated copper screws inserted into the skull bone in the parietal regions. The animals were then allowed a steady-state period of 30 min before induction of ischemia. Ischemia was induced by an intravenous infusion of a vasodilator (Arfonade 5 mg/kg in saline), bilateral clamping of the carotid arteries, and bleeding of the animals to an MABP of 50 mm Hg and an isoelectric EEG (Nordstrom et aI., 1978) . Circulation was restored in the brain by removing the clamps and normalizing the MABP with blood rein fusion. Excessive systemic acidosis was counteracted by intravenous injection of 0.6 M sodium bicarbonate (0.5-1.0 ml). Control animals were subjected to the same op erative procedure but kept artificially ventilated with 30% O2 and 70% N20 for periods similar to those in the ex periments. In all experiments the body temperature was kept close to 37°C by intermittent heating of the operation table. The brain temperature was prevented from falling by a heating bulb placed at a predetermined distance from the head. After freezing of the brain in situ with liquid nitrogen according to Ponten et al. (1973) , the brains were chiseled out during irrigation with liquid nitrogen and stored at -80°C until extraction.
Intravenous injections of glucose were performed via the femoral vein. A glucose solution (10% in saline) was slowly infused and the blood glucose levels determined with a Beckman Glucose Analyzer 2. DCA (Sigma) di luted in distilled water and neutralized to pH 7.4 was given intraperitoneally in a dose of 250 mg/kg four times over 2 h.
Determination of PDHC activity
The frozen brains were brought to -20°C, and the neo cortex (250--300 mg) was dissected out, homogenized (Thomas homogenizer) in 9 ml of 10% sucrose solution on ice at 800 rpm with 10--15 strokes, and subsequently di luted three times with sucrose. If not otherwise stated, all subsequent steps were done on ice. Following centrifu gation at 1,300 g for 3 min (4°C), a crude supernatant was obtained that was divided into two halves. Each super natant was centrifuged at 20,000 g for 10 min and washed once with 10% sucrose solution. The determination of PDHC activity was made essentially according to Baudry et al. (1982) . One pellet was dissolved in a 0.5-ml mixture of 2 mM EGTA, 2.5 mM DCA, and 8 mM sodium fluoride in 0.01 M Tricine buffer (pH 7.9) to inhibit PDH kinase and PDH phosphatase activities, sonicated for 5 min, and used for determination of the active fraction of PDHC (PDHac t ) ' The other pellet was dissolved in a mixture of 1.5 mM CaCI2, 10 mM MgCI2, 2.5 mM DCA, and 0.1 mM dinitrophenol, sonicated for 1 min, and preincubated at 30°C for 30 min. This homogenate was used to determine the total PDHC activity (PDH tot ) ' Protein was determined by the procedure of Lowry et al. (1951) with human se rum albumin as standard.
Mter lysis in the incubation buffers, 15 fLI of the ho mogenates was added to 200 fLI of an assay mixture con taining 2 mM EGTA, 0.1 mM thiaminpyrophosphate, 2.5 mM NAD, 1 mM dithiothreitol, 1.5 mM CoA, 2 fLg lactate dehydrogenase, 1 fLg phosphotransacetylase, and 10 mM MgCI2 in 20 mM Tricine buffer (pH 7.9) and preincubated at 2SOC for 2 min. All reagents were analytical grade and obtained from Sigma. The reaction was started by addi tion of [l-14Clpyruvate (100 cpm/pmol; Amersham) to yield a final pyruvate concentration of 0.5 mM. The ves sel was immediately sealed using a rubber cap holding a plastic container with a filter paper soaked in 150 fLI of tissue solubilizer (TS-l; Zinsser Analytic, Frankfurt, F.R.G.) and shaken in a water bath at 2SOC for 10 min. The liberated 14C02 was captured on the filter paper. The reaction was stopped by addition of 0.2 ml 10% trichlo roacetic acid with a syringe through the rubber cap. The mixture was allowed to stand for an additional 45 min at 25°C. The filter paper was then transferred into a scintil lation vial. Ten milliliters of scintillation solution (Quick scint 501; Zinsser Analytic) was added and the vials were counted in a Beckman f3-scintillation counter. In both cases, PDHC activity was measured as the initial rate of conversion of [1-14Clpyruvate to 14C02, expressed as nmol 14C02/(min-mg protein) or as the ratio PDHac,l PDH tot'
Analysis of energy and glycolytic metabolites
The frozen tissue was brought to -20°C and 20-25 mg of cortical tissue was dissected out. The analysis of phos phocreatine (PCr), ATP, ADP, AMP, glucose, glycogen, lactate, and pyruvate was performed according to Folber grova et al. (1972) .
Analysis of blood gases and pH
Arterial blood (150-200 fLl) was obtained anaerobically and P02, Pe02, and pH were determined with microelec trodes (Eschweiler, Kiel; Radiometer, Copenhagen, Den mark), operated at 37°C, with corrections for the body temperatures of the animals.
Statistics
The data are given as means ± SEM. They were ana lyzed using analysis of variance with a post hoc Dunnett test.
RESULTS
Physiological parameters
In the untreated, saline-treated and DCA + glu cose-treated animals, the preischemic blood P02 was 96-111 mm Hg and Pco2 was 36-38 mm Hg. The body temperature was 37.1-37.2°C, and MABP 131-152 mm Hg. There was no significant differ ence in the parameters among these groups. In the DCA-treated animals, the blood pH was signifi cantly lower than in the saline-treated animals: 7. 29 ± 0.02 (p < 0.05) in DCA-treated and 7.31 ± 0.01 (p < 0.05) in DCA + glucose-treated animals as com pared with 7. 43 ± 0.01.
PDHC activity during and fo llowing cerebral ischemia
In control brains the PDHact was 9. 6 ± 0.5 nmol 14C02/(min-mg protein), which constituted 40% of the total PDHC activity, a value similar to what has been reported by other groups (Morgan and Rout tenberg, 1981; Browning et aI., 1981 ; Baudry et aI., , 1982) . The total PDH activity was 24. 1 ± 1.8 nmol 14C02/(min-mg pro tein), a value comparable with that recently re ported by Hansford and Castro (1985) , but lower than that given others (Booth and Clark, 1978) . Fol lowing 15 min of cerebral ischemia, the activity in creased to 21.4 ± 0.7 14C02/(min-mg protein) or 89% of the total enzyme activity (Fig. 1) . In the recirculation phase, the enzyme activity was signif icantly decreased (p < 0. 01) to 4. 6-4. 8 14C02/(min-mg protein), amounting to 19-26% of the total enzyme activity and thus a decrease by 50% compared with control values (Fig. 1, left) . This decrease in enzyme activity was observed up to 6 h post ischemia. The decrease in postischemic enzyme activity was not due to loss of total enzyme activity PDHtot (Fig. 1, right) .
The changes in energy and glycolytic metabolites in the cerebral cortex are shown in Table 1 . These data are in accordance with earlier published data using this ischemia model (Nordstrom et aI. , 1978) , although here extended to the 6-h time point. The lactate levels increased to 12.3 ± 0.4 /-LmoVg after 15 min of ischemia and decreased in the recovery pe riod to control values, but were still significantly elevated at 15 min of recovery. During ischemia the pyruvate levels decreased owing to NADH accu mulation driving the lactate dehydrogenase reaction toward lactate formation (Nordstrom et aI., 1978) . During the recirculation phase, the levels were ini tially increased to 0.36 ± 0.01 /-LmoVg, but subse quently decreased to control levels. The lactate/ pyruvate ratio was significantly lower than control at 15 min of recirculation but returned to control levels after 60 min. A rapid recovery of the ATP levels to -80% of the control values at 15 min of recirculation was observed. The ATP/ ADP ratio Data are means ± SEM, with n = 6. ··Significant difference from the control group, p < 0.01.
�ON"","-NOO""':..q: was not significantly different from control levels at 15 and 60 min of recirculation, but was decreased slightly at 6 h. In summary, the postischemic de pression of PDHC activity persisted at 6 h following ischemia, although the steady-state levels of energy metabolites were essentially at control levels.
Effects of DCA on PDHC activity and metabolism In another set of experiments, the rats were pre treated with DCA (250 mg/kg four times over a pe riod of 2 h) prior to ischemia. DCA decreased blood glucose levels significantly prior to and following ischemia (Fig. 2) . Thus, another experimental group was made where the DCA-treated animals received an intravenous infusion of glucose to obtain control levels of plasma glucose. In the DCA-treated ani mals, the brain lactate level at the end of the isch emic insult was 9. 3 ± 0.3 fL mollg compared with the levels in control and DCA + glucose-treated ani mals of 12. 4 ± 0.2 and 11. 6 ± 0.7 fL mol/g respec tively. Table 2 shows the PDHC activity in control ani mals and animals subjected to 15 min of ischemia and 15 min of recirculation that were untreated, DCA treated, or DCA + glucose treated. In the control group, the active fraction of PDHC was 46 ± 1%. DCA increased the active fraction of the enzyme to 103 ± 9%, and in the DCA + glucose treated group, the fraction was 95 ± 4%. Thus, an almost complete activation of the enzyme was found. The activation of PDHC by DCA corrobo rates the findings of Abemayor et al. (1984) . In con trast, in the recovery group, DCA was without ef fect on the PDHC activity in the DCA + glucose- 1 %) . We chose the IS-min recovery group to study the effects of DCA on cerebral metabolism and PDHC activity. At this time point, the PDHC activity was depressed and the pyruvate and lactate levels still significantly elevated. The effect of DCA on inter mediary metabolites in control animals and in the 15-min recovery group is shown in Table 3 . The glucose levels were increased in the DCA + glu cose-treated control animals and in the DCA treated recovery group. The glycogen levels were increased in the DCA-treated control group. In DCA + glucose-treated animals, there was a sig nificant decrease in the pyruvate levels in both the control and the recovery groups. There was no sig nificant change in the levels of lactate, but the lactate/pyruvate ratio was significantly increased in the DCA-and DCA + glucose-treated animals. The PCr level was lower in the DCA + glucose treated recovery group. No changes were noted in the ATP/ADP ratio.
DISCUSSION
In the present investigation we demonstrate a postischemic depression of the pyruvate decarbox ylase activity of PDHC in the rat cerebral cortex by -50%, a depression that persists for at least 6 h and is not reversed by DCA, an inhibitor of PDHC ki nase. Furthermore, changes in the steady-state lev els of pyruvate and lactate do not correlate with changes in the PDHC activity. Since we have as sessed the activity of PDHC in an in vitro assay, mechanisms other than direct allosteric regulation of the enzyme by, for example, the ratios NADHINAD and acetylCoAiCoA must be consid ered to explain these effects. In the following dis cussion we will focus on the enzymes responsible J Cereb Blood Flow Metab, Vol. 9, No. 3, 1989 15.1 ± 0.6 0.31 ± 0.01
for the phosphorylation-dephosphorylation of PDHC. We envisage that an imbalance between the PDH kinase and PDH phosphatase activity prevails in the postischemic cortex, leading to a net de pressed PDHC activity. One possibility is an enhanced PDH kinase activ ity in the postischemic phase. The kinase is regu lated mainly by metabolites of intermediary metab olism and is dependent on potassium and ammo nium ions (Reed, 1981; Lai and Sheu, 1985) . An increase in the NADH/NAD and ATP/ADP ratios stimulates the kinase and thus decreases the PDHC activity (Hansford, 1976; Lai and Sheu, 1985) . Since we do not see an increase in the lactate/ pyruvate ratio, which would be the effect of an in creased NADH/NAD ratio, and since it has been shown that the NADHINAD ratio is at or below control levels following ischemia (Rosenthal et aI., 1976; Welsh, 1985; Kogure et aI., 1985) , a change in the NADH/NAD ratio is not responsible for the PDHC depression. The ATP/ADP ratio is not changed in the recovery period compared with con trol levels, at least up to 60 min of recovery. During ischemia the extracellular levels of potassium ions increase and consequently intracellular levels de crease owing to membrane depolarization, but are rapidly restored in the postischemic phase (Si emkowicz and Hansen, 1981; Harris and Symon, 1984) . We thus find it unlikely that an activation of PDH kinase is responsible for the depressed PDHC activity. The effects of DCA on PDHC activity cor roborate this conclusion. The DCA given in a dose sufficient to inhibit PDH kinase in control animals failed to activate PDHC in the postischemic period. Unless the kinase has become resistant to DCA in hibition because of ischemia, the straightforward explanation is an inhibition of the PDH phos phatase, leading to a decreased PDHC activity.
DCA induced some specific changes in the steady-state levels of energy metabolites. The changes in brain glucose and glycogen levels in the DCA-treated animals during and following ischemia N C!; .... 000
N""':N are most probably due to effects on changes in blood glucose levels. In contrast, the 50% decrease in pyruvate concentration in both DCA-and DCA + glucose-treated animals probably is caused by an effect of DCA on cellular metabolism. Since no ac tivation of PDHC with DCA was noted at 15 min of recirculation, the decreased levels of pyruvate could not be explained by a change in PDHC activ ity. A decrease in intracellular pH could account for the observed increase in lactate/pyruvate ratio, as was also found in hypercapnia (Folbergrova et al., 1972) , and which is also indicated by the decreased PCr levels in the DCA + glucose-treated animals. However, the observed changes in intermediary metabolism apparently did not affect the PDHC ac tivity. We are thus inclined to conclude that the postischemic PDHC depression most probably is not due to changes in the steady-state levels of in termediary glycolytic and energy metabolites acting via activation of PDH kinase activity, but presum ably due to a decrease in PDH phosphatase activity.
The PDH phosphatase in brain is dependent on calcium and magnesium ions (Sheu et aI. , 1983) as described in peripheral tissue (Reed, 1981) . The ef fects of calcium and magnesium ions on PDHC have been thoroughly investigated and a hypothesis has been proposed suggesting that the intramito chondrial calcium ion concentration regulates PDHC activity via modulation of the phosphatase activity (Denton and McCormack, 1980; Hansford, 1985; McCormack and Denton, 1986) . However, other alternatives must also be taken into account, such as postischemic changes in intramitochondrial concentrations of magnesium ions (Sheu et aI. , 1983) , decreased spermine levels (Damuni et aI. , 1984; Paschen et aI., 1987) , or a decreased release of an insulin-like neuromodulator (Seals and Czech, 198 1; Thomas and Denton, 1986) . Another explana tion for the decreased PDH phosphatase activity could be a decrease in the actual amount of the enzyme.
At this stage the implication of depressed PDHC activity for postischemic brain pathology is difficult to envisage. If PDHC becomes the rate-limiting step in aerobic glucose oxidation in the postischemic brain, the postischemic PDHC depression may ac count for the metabolic depression observed follow ing transient periods of cerebral ischemia (Pulsinelli et aI., 1982) . Further correlative investigations of PDHC activity and cerebral metabolism may give valuable information on PDHC regulation and its functional importance in the postischemic brain, such as the intimate relationship between transmit ter receptor interaction and calcium fluxes across the mitochondrial membrane.
